ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,802.82
      -0.67%
      US Tech 100
      20,331.20
      -1.11%
      Dow Jones
      41,603.07
      -0.61%
      Brent Oil
      64.525
      1.41%
      Bitcoin
      107,454.09
      -3.84%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Invivyd Inc (IVVD) Quote

      Invivyd Inc

      Invivyd Inc (IVVD)

      NASDAQ
      0.7485
      -0.012
      (-1.58%)
      At close: May 23 4:00PM
      15 min delayed - Upgrade to Realtime
      0.727
      -0.0215
      ( -2.87% )
      After Hours: 7:13PM
      15 min delayed - Upgrade to Realtime

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      0.727
      Bid
      0.713
      Ask
      0.74
      Volume
      5,595,207
      0.7002 Day's Range 0.7897
      0.3546 52 Week Range 2.74
      Market Cap
      87.212M
      Previous Close
      0.7605
      Open
      0.781
      Last Trade
      370
      @
      0.727
      (formt)
      Last Trade Time
      19:13:23
      Financial Volume
      $ 4,127,273
      VWAP
      0.737644
      Average Volume (3m)
      2,221,489
      Shares Outstanding
      119,961,445
      Dividend Yield
      -
      PE Ratio
      -3.28
      Earnings Per Share (EPS)
      -1.42
      Revenue
      25.38M
      Net Profit
      -169.93M

      About Invivyd Inc

      Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and ... Invivyd Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's lead product candidate, ADG20 is developed for the treatment and prevention of coronavirus disease which has demonstrated clinically meaningful results in global Phase 3 clinical trials against multiple variants of concern for the prevention and treatment of COVID-19. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      invivyd.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Invivyd Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker IVVD. The last closing price for Invivyd was $0.76. Over the last year, Invivyd shares have traded in a share price range of $ 0.3546 to $ 2.74.

      Invivyd currently has 119,961,445 shares outstanding. The market capitalization of Invivyd is $91.23 million. Invivyd has a price to earnings ratio (PE ratio) of -3.28.

      Ask ADVFN Intelligence (AI)

      IVVD Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 12 2025
      IVVD (-1.58%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      April 25 2025
      IVVD (-1.58%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      April 21 2025
      IVVD (-1.58%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.02523.590766600170.70180.83720.701213043010.77793483CS
      40.06710.15151515150.661.090.492622841170.70456822CS
      12-0.463-38.90756302521.191.270.4622214890.74470868CS
      260.00741.028349082820.71962.740.354684032121.22950527CS
      52-1.423-66.18604651162.152.740.354643584581.22273528CS
      156-3.973-84.53191489364.75.1950.354619613581.54514232CS
      260-3.973-84.53191489364.75.1950.354619613581.54514232CS

      IVVD - Frequently Asked Questions (FAQ)

      What is the current Invivyd share price?
      The current share price of Invivyd is $ 0.727
      How many Invivyd shares are in issue?
      Invivyd has 119,961,445 shares in issue
      What is the market cap of Invivyd?
      The market capitalisation of Invivyd is USD 91.23M
      What is the 1 year trading range for Invivyd share price?
      Invivyd has traded in the range of $ 0.3546 to $ 2.74 during the past year
      What is the PE ratio of Invivyd?
      The price to earnings ratio of Invivyd is -3.28
      What is the cash to sales ratio of Invivyd?
      The cash to sales ratio of Invivyd is 21.93
      What is the reporting currency for Invivyd?
      Invivyd reports financial results in USD
      What is the latest annual turnover for Invivyd?
      The latest annual turnover of Invivyd is USD 25.38M
      What is the latest annual profit for Invivyd?
      The latest annual profit of Invivyd is USD -169.93M
      What is the registered address of Invivyd?
      The registered address for Invivyd is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
      What is the Invivyd website address?
      The website address for Invivyd is invivyd.com
      Which industry sector does Invivyd operate in?
      Invivyd operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      WORXSCWorx Corporation
      $ 0.569
      (41.37%)
      		20.09M
      DGLYDigital Ally Inc
      $ 3.00
      (20.00%)
      		624.14k
      LIMNLiminatus Pharma Inc
      $ 6.4999
      (16.90%)
      		1.36k
      GMHSGamehaus Holdings Inc
      $ 1.49
      (15.50%)
      		3.06k
      CODXCo Diagnostics Inc
      $ 0.2523
      (8.94%)
      		20.57k
      PRTAProthena Corporation PLC
      $ 4.91
      (-25.38%)
      		677.54k
      PMAXPowell Max Ltd
      $ 0.383
      (-24.89%)
      		5.06M
      IMNNImunon Inc
      $ 0.91
      (-21.55%)
      		43.2M
      PLRZPolyrizon Ltd
      $ 0.0028
      (-17.65%)
      		113.78M
      SGBXSafe and Green Holdings Corporation
      $ 0.5301
      (-11.65%)
      		303.51k
      PLRZPolyrizon Ltd
      $ 0.0028
      (-17.65%)
      		113.78M
      IMNNImunon Inc
      $ 0.91
      (-21.55%)
      		43.2M
      HCTIHealthcare Triangle Inc
      $ 0.0053
      (-8.62%)
      		26.31M
      WORXSCWorx Corporation
      $ 0.569
      (41.37%)
      		20.09M
      CETYClean Energy Technologies Inc
      $ 0.4026
      (1.67%)
      		11.85M

      IVVD Discussion

      View Posts
      eur06 eur06 12 hours ago
      Great news it’ll go a long way imo
      Lots of manipulation as expected, but soon enough.
      IVVD
      👍️0
      eur06 eur06 3 days ago
      Great!
      I did add and moving up.
      IVVD
      👍️0
      dinogreeves dinogreeves 3 days ago
      I am still here.
      👍️0
      glenn1919 glenn1919 5 days ago
      IVVD.................................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
      👍️0
      eur06 eur06 6 days ago
      Got you…it’s true bid is solidly maintained with intent!
      Glad you spotted that.
      Go IVVD!
      👍️0
      dinogreeves dinogreeves 6 days ago
      Bid support.
      👍️0
      eur06 eur06 6 days ago
      How can you tell retail not the one controlling ?
      I’m glad though.
      IVVD
      👍️0
      eur06 eur06 1 week ago
      Great I’ll be adding until under $1.
      IVVD
      👍️0
      dinogreeves dinogreeves 1 week ago
      Now its official that retail does not control this ticker with 100 million float, this is going to breakout.
      👍 1
      eur06 eur06 1 week ago
      It is right now!!
      It will be a great one.
      IVVD
      👍️0
      dinogreeves dinogreeves 1 week ago
      Whoever wanted to bail yesterday bailed after the report.
      👍️0
      dinogreeves dinogreeves 1 week ago
      I believe this will breakout at some point. The bank loan was given for a reason, Peter Thiel assigned his partner a board seat with the company who is also anti vaccine, this company has a different approach than all the other vaccine companies.
      👍️0
      eur06 eur06 1 week ago
      I believe your assessment of this company!!
      I’m going to add this morning.
      IVVD
      👍️0
      eur06 eur06 1 week ago
      I think two weeks waiting is reasonable.
      All those names involved could mean something I’m waiting.
      IVVD
      👍️0
      familyof5 familyof5 1 week ago
      I suppose. But you went on another board not related to IVVD and responded to a post of mine not related to IVVD and said "Just BUY IVVD". https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176184308 I had never heard of IVVD until that moment. You reached out to me with the idea I didn't reach out to you inquiring about it. At the moment you said BUY it was trading over 1.00. Since you reached out to me I trusted you. Sometimes it's not as simple as "You win some, you lose some". I've seen you all over ihub scolding others for misleading the gullible and thought maybe you were sincere. Now I hear you short some of your so called long plays. One minute this is the next Holy Grail https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176184536 and the next you'll give it 2 or 3 weeks. PSALMS 37 .....and I thought you were being sincerely genuine when you reached out to me with the IVVD buy idea.
      👍 1
      dinogreeves dinogreeves 1 week ago
      You win some, you lose some. I was not expecting much from ER, I am expecting something the next three months, but if this doesn't pick up steam in the next 2-3 weeks, I will be out and book my losses.
      👍️0
      familyof5 familyof5 1 week ago
      First OM_X now IVVD. Hard to put a smile on ones face and move on when you've basically been wiped out. I'm not independently wealthy. I saw the short set up and I brushed it off because I wanted to believe more than I wanted to listen. Can't believe you got duped as well.
      👍️0
      dinogreeves dinogreeves 1 week ago
      I am down too, no reason for this big drop at all. Going to wait on this one to breakout, two weeks, if not then I will sell and move on.
      👍️0
      familyof5 familyof5 1 week ago
      ouch.....this one has hurt me. Hurt me bad. Bad enough I don't think I recover. I took a leap of faith.....




      dinogreeves Re: familyof5
      Tuesday, May 13, 2025 11:18:27 AM

      Just buy $IVVD. Peter Thiel, Vance and Lutnick are involved, plus if Measles spreads, this can easily hit ten dollars by year end.
      👍️0
      dinogreeves dinogreeves 1 week ago
      This is a big gap down for panic selling.
      👍️0
      eur06 eur06 1 week ago
      ER not too good but we’re in for progress in next few months I guess.
      Time to add with panic selling imo.
      IVVD
      👍️0
      eur06 eur06 1 week ago
      In any case earnings tomorrow let’s see if they are good.
      IVVD
      👍️0
      dinogreeves dinogreeves 1 week ago
      News this morning.
      👍️0
      dinogreeves dinogreeves 1 week ago
      You just read my mind, I know exactly how this happened today, I posted on this board for a reason so I can make them mad and they dip it so I can buy more, I bought in the mid 70's and again today in the high 80's. Not going anywhere with this one, May 15th premarket company earnings report is suppose to be announced. Peter Thiel is on board, he has one of the hedge fund managers a board seat as a director of this company, who is anti vaccine, much less Lutnick and Vance. Now, all depends on how the measles spread across the US and Worldwide, if it spreads like Covid, then all bets are off. I had Moderna at 16 dollars, sold for double, but yet just one year later it hit, over 500 dollars in premarket. This has all the making of making a powerful run, by far better than Vaxart did during covid era. Banks don't give out loans if you don't have something tangible as a collateral, hey at least there is no immediate dilution. Once the masses find out about this, we will run hard. Good luck bud. The more they dip, the more I will buy. Read my posts below on Moderna.


      https://investorshub.advfn.com/boards/memberpoststoboard.aspx?userid=552395&boardid=36438
      👍 1
      familyof5 familyof5 1 week ago
      You must have made someone mad because someone was working really hard the last half of the trading day to keep this from running. I mean really hard. I took advantage of it and took a LONG POSITION in the upper 8’s. Sooner or later your going to put me on a runner. You got to start giving me a heads up before you load up on it though my friend?
      👍️0
      eur06 eur06 1 week ago
      Great information!!
      IVVD
      👍️0
      eur06 eur06 1 week ago
      Thanks!!
      Still accumulating the other as well.
      IVVD
      👍️0
      dinogreeves dinogreeves 1 week ago
      Peter Thiel holds a significant position in INVIVYD Inc. (formerly known as Adagio Therapeutics), a biotechnology company focused on developing monoclonal antibody therapies for infectious diseases.
      MarketScreener

      🧬 Thiel’s Role and Ownership
      Thiel is affiliated with Mithril Capital Management, a venture capital firm he co-founded. Through Mithril II LP, Thiel owns approximately 11.2 million shares of INVIVYD, representing about 10.2% of the company. These shares are held of record by Mithril II, with Thiel and Ajay Royan serving on the investment committee of Mithril II GP, the general partner of Mithril II. As members of the investment committee, Thiel and Royan share voting, investment, and dispositive power over these shares .
      MarketScreener
      Sec Form 4
      +3
      Invivyd Investors
      +3
      Invivyd Investors
      +3

      🧑‍⚖️ Influence on Corporate Governance
      In March 2022, Mithril Capital Management, through Mithril II LP, reached an agreement with other shareholders to coordinate efforts in nominating candidates to INVIVYD’s board of directors. This move indicates Thiel's active involvement in shaping the company's leadership and strategic direction .
      MarketScreener
      👍️0
      dinogreeves dinogreeves 1 week ago
      This is a beauty. I did my research last couple of days. This will reach multi billion market cap by end of next year.

      👍️0
      glenn1919 glenn1919 1 week ago
      IVVD.....................................................p/m
      👍️0
      glenn1919 glenn1919 2 weeks ago
      IVVD........................................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
      👍️0
      makinezmoney makinezmoney 2 weeks ago
      $IVVD: Shes on a roll here....... now $0.60

      Some news come out or something ?

      Lemme know

      Bouncing now


      GO $IVVD
      👍️0
      glenn1919 glenn1919 3 months ago
      IVVD..........................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
      👍️0
      Viewmont Viewmont 3 months ago
      $IVVD WALTHAM, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that Marc Elia, Chairman of the Invivyd Board of Directors, will be presenting at the Oppenheimer 35th Annual Healthcare Life Sciences Conference.

      The presentation is set to take place at 1:20 PM ET on Wednesday, February 12th. The live webcast link will be available in the investor section of the company's website at https://investors.invivyd.com and will be archived for approximately 90 days following the event.

      About Invivyd
      Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
      👍️0
      Viewmont Viewmont 3 months ago
      $IVVD On February 3, 2025, the Company issued a press release entitled “Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population.” A copy of the press release is filed herewith as Exhibit 99.2 and is incorporated by reference in this Item 8.01.
      👍️0
      glenn1919 glenn1919 3 months ago
      IVVD..........................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
      👍️0
      glenn1919 glenn1919 3 months ago
      IVVD......................https://stockcharts.com/h-sc/ui?s=IVVD&p=W&b=5&g=0&id=p86431144783
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      IVVD: L.O.L.!!! (That must be TRUMP's ass --- and the backside of his 'MAGNA' hat!!!)
      👍️0
      B RY B RY 3 months ago
      Here's a nice fluffy pillow similar to other companies pr's, lol.>>>

      👍️0
      B RY B RY 3 months ago
      Very true! I'll take an ivvd fda phase 3 talks with an 8k showing stronger financial strength over the fluff pr's other companies put out anyday.

      👍️0
      Invest-in-America Invest-in-America 3 months ago
      IVVD: Very-well-stated, Dude!! (And yet every day we see yet another bogus, Pre-Clinical, study in useless Petri Dishes, Test Tubes, or in the ass of MICE!! And worse yet of late, mere "DIGITAL STUDIES" in a cheap Apple Laptop COMPUTER!!!)
      👍️0
      B RY B RY 3 months ago
      Shorting ivvd currently is financial roulette imo.
      👍️0
      B RY B RY 3 months ago
      I like their product being in phase 3 discussions with the fda. Phase 1 means a company is lucky to hear back from the fda. Phase 2 means the product is worth the fda's time to open discussion. Phase 3 means the fda is in serious talks about approving the product and in deep discussion with the company. Phase 4 is the final fda approval process discussions covering any unanswered fda questions and closing dialogue. That being said, I love seeing ivvd in phase 3 talks. Upon fda approval, this company should show profitable within a year or so from where it is now financially. The "emergency use" status will be a mute point with it's product fda approved for sale. I'm looking forward to seeing it's financial position in a couple of years. We have a real winner imo Invest.
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      IVVD: This thing had soared HUGELY in just 3-days --- nearly 600%. But now, it's pure guess work. (EVERY company everywhere is now suddenly touting their 'revolutionary', disruptive, all-new, QUANTUM-AI-CUSTOM-TAILORED-HEALTHCARE, routines.)
      👍️0
      Stockexpertpro Stockexpertpro 3 months ago
      GSIW 1$ Breakout Coming Shorts will have to Buy to Cover
      👍️0
      B RY B RY 3 months ago
      I would love to sell my ivvd and buy below $2, but I seriously doubt it will retrace below $2 for more than a couple of pennies. The upcoming march 28th annual report will be too highly anticipated after monday's 8k. This ivvd ride will most certainly be the most stock fun I've had in a while. I prefer downhill skiing for a good rush, but I think as far as stocks are concerned, ivvd will prove to have a good rush as well. It's 12 month $7.89 price target will come much sooner imo. I still think testing politicians first is a good idea.
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      IVVD: Indeed; and Trump already had to do that in his FIRST term, behind getting that first Covid-19 vaccine launched.
      👍️0
      B RY B RY 3 months ago
      "Emergency use Authorization" will prove a huge asset.
      👍️0
      Invest-in-America Invest-in-America 3 months ago
      IVVD: I think Trump, Vance, & Musk, et al., are somehow cleverly-affiliated with this Firm --- especially in light of Trump's recent public digressions about how Quantum-AI-Tech will very soon be able to create TAILOR-MADE therapeutics, vaccines, treatments, inter alia, for any INDIVIDUAL patient suffering from all manner of Human afflictions; which is precisely what the IVVD company is attempting to do.
      👍️0
      B RY B RY 3 months ago
      The strong buying since feb 3rd's "Results of Operations and Financial Conditions" 8k is in 7 weeks(mar 27th/28th) the 2024 10K will reveal the details from monday's much improved financial outlook. It will be highly anticipated reading and good reason for strong price increases leading up to it and beyond. This company much needed the turn around it's experiencing that took years in the making. Good luck to your long investments aside from the fun we have day trading most stocks. I think I'll unload a couple of my other long holds that are currently dormant. Ivvd has much more promise.

      👍️0

      Your Recent History

      NASDAQ
      IVVD
      Invivyd
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads